Sunshine Lake Pharma Co., Ltd. (HKG:6887)

Sunshine Lake Pharma Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	28,348	31,912	31,678	21,698	20,362	29,475
Market Cap Growth	-16.74%	0.74%	46.00%	6.56%	-30.92%	-60.53%
Enterprise Value	29,229	32,789	32,627	25,107	22,732	29,668
Last Close Price	49.16	32.84	32.60	22.33	20.95	30.33
PE Ratio	22.20	62.12	14.43	250.55	-	29.57
PS Ratio	7.15	8.05	4.57	5.13	18.15	10.57
PB Ratio	3.13	3.53	3.62	3.16	2.76	4.86
P/TBV Ratio	3.65	4.11	4.45	4.68	4.53	7.57
P/FCF Ratio	-	-	21.63	16.99	-	81.29
P/OCF Ratio	297.91	335.37	17.18	11.29	-	19.10
EV/Sales Ratio	7.38	8.27	4.71	5.93	20.27	10.64
EV/EBITDA Ratio	25.79	29.28	9.34	32.12	-	26.29
EV/EBIT Ratio	41.04	46.06	10.61	68.82	-	29.97
EV/FCF Ratio	-31.25	-	22.28	19.66	-	81.82
Debt / Equity Ratio	0.26	0.26	0.33	0.63	0.53	0.59
Debt / EBITDA Ratio	2.10	2.10	0.82	5.46	-	3.15
Debt / FCF Ratio	-	-	1.96	3.38	-	9.86
Asset Turnover	0.30	0.30	0.51	0.33	0.09	0.24
Inventory Turnover	1.76	1.76	3.62	3.02	1.31	1.20
Quick Ratio	1.29	1.29	0.87	0.46	1.36	0.64
Current Ratio	1.77	1.77	1.40	1.01	1.66	0.78
Return on Equity (ROE)	5.87%	5.87%	26.50%	0.81%	-10.57%	17.22%
Return on Assets (ROA)	3.32%	3.32%	14.16%	1.80%	-2.85%	5.35%
Return on Capital (ROIC)	3.93%	3.93%	17.07%	2.11%	-3.30%	6.61%
Return on Capital Employed (ROCE)	7.00%	7.00%	33.20%	4.60%	-	15.40%
Earnings Yield	1.81%	1.61%	6.93%	0.40%	-3.54%	3.38%
FCF Yield	-3.30%	-2.93%	4.62%	5.89%	-6.14%	1.23%
Dividend Yield	11.37%	-	-	-	-	1.49%
Payout Ratio	-	-	-	-	-	26.21%
Buyback Yield / Dilution	-	-	-	-	20.42%	-9.51%
Total Shareholder Return	11.37%	-	-	-	20.42%	-8.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.